Cytovac Competitors and Similar CompaniesClear all
Cytovac's competitors and similar companies include T3 Pharmaceuticals, SpecificiT Pharma, CiMaas and Mercia Pharma.
 Cytovac Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of immunotherapies with a primary focus on orphan diseases. |  T3 Pharmaceuticals T3 Pharmaceuticals is a biopharmaceutical company developing therapies for cancer patients. |  SpecificiT Pharma SpecificiT Pharma a biopharmaceutical company that focuses on developing cellular therapies for hematological cancers. |  Mercia Pharma Mercia Pharma is a biotech company that develops disease-specific immunotherapeutic products. | ||
Founding Date | Founding Date 2008 | Founding Date 2015 | Founding Date 2016 | Founding Date 2015 | Founding Date N/A |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Hørsholm, DK HQ | Locations Basel, CH HQ | Locations Montréal, CA HQ | Locations Maastricht, NL HQ Maastricht, NL | Locations HQ |
Employees | Employees 713% decrease | Employees 26 | Employees 150% decrease | Employees 350% increase | Employees 6 |
For sources of this data, please see the company profile
View Company Profiles
T3 Pharmaceuticals
HQ
Basel, CH
Employees
26
T3 Pharmaceuticals is a biopharmaceutical company developing therapies for cancer patients.
View companySpecificiT Pharma
HQ
Montréal, CA
Employees
1↓ 50% decrease
SpecificiT Pharma a biopharmaceutical company that focuses on developing cellular therapies for hematological cancers.
View company
CiMaas
HQ
Maastricht, NL
Employees
3↑ 50% increase
CiMaas is a company that develops immunotherapy for cancer by engaging the immune system.
View companyMercia Pharma
HQ
Employees
6
Mercia Pharma is a biotech company that develops disease-specific immunotherapeutic products.
View company